Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma

Internal Medicine

Volumn 47, Issue 18, 2008, Pages 1555-1559

  Yamaguchi, Kanako ^a   Iwakiri, Ryuichi ^a   Hara, Megumi ^a   Kikkawa, Atsushi ^a   Fujise, Takehiro ^a   Ootani, Hibiki ^a   Shimoda, Ryo ^a   Tsunada, Seiji ^a   Sakata, Hiroyuki ^a   Ushiyama, Osamu ^a   Koarada, Syuichi ^a   Tada, Yoshifumi ^a   Nagasawa, Kohei ^a   Fujimoto, Kazuma ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Collagen disease; Endoscopy; Gastroesophageal reflux disease; Helicobacter pylori IgG; Los Angeles Classification

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; REFLUX ESOPHAGITIS; SCLERODERMA;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS, PEPTIC; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; SCLERODERMA, SYSTEMIC;

EID: 56349096745     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1128     Document Type: Article

References (29)

1. Lock G, Holstege A, Lang B, Scholmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 92: 763-771, 1997.
2. Zamost BJ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 92: 421-428, 1987.
3. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 93: 1085-1089, 1998.
4. Aubert A, Lazareth I, Vayssairat M, Fiessinger JN, Petite JP. Esophagitis in progressive systemic scleroderma. Prevalence and risk factors in forty-six patients. Gastroenterol Clin Biol 15: 945-949, 1991.
5. Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 21: S15-S18, 2003.
6. McNamara D, O'Morain C. Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation. Gut 45 (Suppl 1): I13-I17, 1999.
7. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 61: 6-13, 2000.
8. Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 14: 427-432, 2000.
9. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111: 85-92, 1996.
10. Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 44: 541-547, 1996.
11. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315, 1984.
12. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338: 1175-1176, 1991.
13. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341: 1359-1362, 1993.
14. Reinauer S, Goerz G, Ruzicka T, Susanto F, Humfeld S, Reinauer H. Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication. Acta Derm Venereol 74: 361-363, 1994.
15. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 100: 1495-1501, 1991.
16. Aragona P, Magazzu G, Macchia G, et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome. J Rheumatol 26: 1306-1311, 1999.
17. Yazawa N, Fujimoto M, Kikuchi K, et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 25: 650-653, 1998.
18. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 94: 3468-3472, 1999.
19. Yamaji Y, Mitsushima T, Ikuma H, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 49: 335-340, 2001.
20. Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol 99: 1213-1221, 2004.
21. Haruma K, Hamada H, Mihara M, et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 5: 24-29, 2000.
22. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326: 737-743, 2003.
23. Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 99: 1652-1656, 2004.
24. Blom-Bulow B, Sundstrom G, Jonson B, Tylen U, Wollheim FA. Early changes in oesophageal function in progressive systemic sclerosis: a comparison of manometry and radiology. Clin Physiol 4: 147-158, 1984.
25. Murphy JR, McNally P, Peller P, Shay SS. Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 37: 833-841, 1992.
26. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37: 1265-1282, 1994.
27. Al-Amri SM. The pattern of esophageal manometry in progressive systemic sclerosis. Saudi Med J 24: 68-71, 2003.
28. Asaka M, Kimura T, Kudo M, Tkaeda H, Mitani S, Miyazaki T, Graham DY. Relationship between Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102: 760-766, 1992.
29. Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 95: 2094-2099, 1999.